 | • レポートコード：QFJ1-5854 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、転移性骨疾患の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、放射線療法、外科的介入、腫瘍切除療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・転移性骨疾患の市場動向 ・企業の競争状況、市場シェア ・転移性骨疾患の種類別市場規模と予測2016-2027（薬物療法、放射線療法、外科的介入、腫瘍切除療法） ・転移性骨疾患の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・転移性骨疾患の北米市場規模2016-2027（アメリカ、カナダ） ・転移性骨疾患の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・転移性骨疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・転移性骨疾患の中南米市場規模2016-2027（メキシコ、ブラジル） ・転移性骨疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Merck & Co、Roche、Novartis、Eli Lilly and Company、Bayer、Fresenius Kabi、BTG plc、Boston Scientific、Medtronic） ・結論 |
Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs.
Market Analysis and Insights: Global Metastatic Bone Disease Market
The global Metastatic Bone Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Bone Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Bone Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Bone Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Bone Disease market.
Global Metastatic Bone Disease Scope and Market Size
Metastatic Bone Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Bone Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medication
Radiation Therapy
Surgical Intervention
Tumor Ablation Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Merck & Co
Roche
Novartis
Eli Lilly and Company
Bayer
Fresenius Kabi
BTG plc
Boston Scientific
Medtronic
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Bone Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Radiation Therapy
1.2.4 Surgical Intervention
1.2.5 Tumor Ablation Therapy
1.3 Market by Application
1.3.1 Global Metastatic Bone Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Bone Disease Market Perspective (2016-2027)
2.2 Metastatic Bone Disease Growth Trends by Regions
2.2.1 Metastatic Bone Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Bone Disease Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Bone Disease Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Bone Disease Industry Dynamic
2.3.1 Metastatic Bone Disease Market Trends
2.3.2 Metastatic Bone Disease Market Drivers
2.3.3 Metastatic Bone Disease Market Challenges
2.3.4 Metastatic Bone Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Bone Disease Players by Revenue
3.1.1 Global Top Metastatic Bone Disease Players by Revenue (2016-2021)
3.1.2 Global Metastatic Bone Disease Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Bone Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Bone Disease Revenue
3.4 Global Metastatic Bone Disease Market Concentration Ratio
3.4.1 Global Metastatic Bone Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Bone Disease Revenue in 2020
3.5 Metastatic Bone Disease Key Players Head office and Area Served
3.6 Key Players Metastatic Bone Disease Product Solution and Service
3.7 Date of Enter into Metastatic Bone Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastatic Bone Disease Breakdown Data by Type
4.1 Global Metastatic Bone Disease Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Bone Disease Forecasted Market Size by Type (2022-2027)
5 Metastatic Bone Disease Breakdown Data by Application
5.1 Global Metastatic Bone Disease Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Bone Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Metastatic Bone Disease Market Size (2016-2027)
6.2 North America Metastatic Bone Disease Market Size by Type
6.2.1 North America Metastatic Bone Disease Market Size by Type (2016-2021)
6.2.2 North America Metastatic Bone Disease Market Size by Type (2022-2027)
6.2.3 North America Metastatic Bone Disease Market Size by Type (2016-2027)
6.3 North America Metastatic Bone Disease Market Size by Application
6.3.1 North America Metastatic Bone Disease Market Size by Application (2016-2021)
6.3.2 North America Metastatic Bone Disease Market Size by Application (2022-2027)
6.3.3 North America Metastatic Bone Disease Market Size by Application (2016-2027)
6.4 North America Metastatic Bone Disease Market Size by Country
6.4.1 North America Metastatic Bone Disease Market Size by Country (2016-2021)
6.4.2 North America Metastatic Bone Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metastatic Bone Disease Market Size (2016-2027)
7.2 Europe Metastatic Bone Disease Market Size by Type
7.2.1 Europe Metastatic Bone Disease Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Bone Disease Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Bone Disease Market Size by Type (2016-2027)
7.3 Europe Metastatic Bone Disease Market Size by Application
7.3.1 Europe Metastatic Bone Disease Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Bone Disease Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Bone Disease Market Size by Application (2016-2027)
7.4 Europe Metastatic Bone Disease Market Size by Country
7.4.1 Europe Metastatic Bone Disease Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Bone Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Bone Disease Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Bone Disease Market Size by Type
8.2.1 Asia-Pacific Metastatic Bone Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Bone Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Bone Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Bone Disease Market Size by Application
8.3.1 Asia-Pacific Metastatic Bone Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Bone Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Bone Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Bone Disease Market Size by Region
8.4.1 Asia-Pacific Metastatic Bone Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Bone Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastatic Bone Disease Market Size (2016-2027)
9.2 Latin America Metastatic Bone Disease Market Size by Type
9.2.1 Latin America Metastatic Bone Disease Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Bone Disease Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Bone Disease Market Size by Type (2016-2027)
9.3 Latin America Metastatic Bone Disease Market Size by Application
9.3.1 Latin America Metastatic Bone Disease Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Bone Disease Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Bone Disease Market Size by Application (2016-2027)
9.4 Latin America Metastatic Bone Disease Market Size by Country
9.4.1 Latin America Metastatic Bone Disease Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Bone Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Bone Disease Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Bone Disease Market Size by Type
10.2.1 Middle East & Africa Metastatic Bone Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Bone Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Bone Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Bone Disease Market Size by Application
10.3.1 Middle East & Africa Metastatic Bone Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Bone Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Bone Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Bone Disease Market Size by Country
10.4.1 Middle East & Africa Metastatic Bone Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Bone Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Metastatic Bone Disease Introduction
11.1.4 Amgen Revenue in Metastatic Bone Disease Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Metastatic Bone Disease Introduction
11.2.4 Merck & Co Revenue in Metastatic Bone Disease Business (2016-2021)
11.2.5 Merck & Co Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Metastatic Bone Disease Introduction
11.3.4 Roche Revenue in Metastatic Bone Disease Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Metastatic Bone Disease Introduction
11.4.4 Novartis Revenue in Metastatic Bone Disease Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Metastatic Bone Disease Introduction
11.5.4 Eli Lilly and Company Revenue in Metastatic Bone Disease Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Metastatic Bone Disease Introduction
11.6.4 Bayer Revenue in Metastatic Bone Disease Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Metastatic Bone Disease Introduction
11.7.4 Fresenius Kabi Revenue in Metastatic Bone Disease Business (2016-2021)
11.7.5 Fresenius Kabi Recent Development
11.8 BTG plc
11.8.1 BTG plc Company Details
11.8.2 BTG plc Business Overview
11.8.3 BTG plc Metastatic Bone Disease Introduction
11.8.4 BTG plc Revenue in Metastatic Bone Disease Business (2016-2021)
11.8.5 BTG plc Recent Development
11.9 Boston Scientific
11.9.1 Boston Scientific Company Details
11.9.2 Boston Scientific Business Overview
11.9.3 Boston Scientific Metastatic Bone Disease Introduction
11.9.4 Boston Scientific Revenue in Metastatic Bone Disease Business (2016-2021)
11.9.5 Boston Scientific Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Details
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Metastatic Bone Disease Introduction
11.10.4 Medtronic Revenue in Metastatic Bone Disease Business (2016-2021)
11.10.5 Medtronic Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Metastatic Bone Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medication
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Surgical Intervention
Table 5. Key Players of Tumor Ablation Therapy
Table 6. Global Metastatic Bone Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metastatic Bone Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Metastatic Bone Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Metastatic Bone Disease Market Share by Regions (2016-2021)
Table 10. Global Metastatic Bone Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Metastatic Bone Disease Market Share by Regions (2022-2027)
Table 12. Metastatic Bone Disease Market Trends
Table 13. Metastatic Bone Disease Market Drivers
Table 14. Metastatic Bone Disease Market Challenges
Table 15. Metastatic Bone Disease Market Restraints
Table 16. Global Metastatic Bone Disease Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Metastatic Bone Disease Market Share by Players (2016-2021)
Table 18. Global Top Metastatic Bone Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Bone Disease as of 2020)
Table 19. Ranking of Global Top Metastatic Bone Disease Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Metastatic Bone Disease Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Metastatic Bone Disease Product Solution and Service
Table 23. Date of Enter into Metastatic Bone Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Metastatic Bone Disease Revenue Market Share by Type (2016-2021)
Table 27. Global Metastatic Bone Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Metastatic Bone Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Metastatic Bone Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Metastatic Bone Disease Revenue Market Share by Application (2016-2021)
Table 31. Global Metastatic Bone Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Metastatic Bone Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Metastatic Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Metastatic Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Metastatic Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Metastatic Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Metastatic Bone Disease Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Metastatic Bone Disease Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Metastatic Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Metastatic Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Metastatic Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Metastatic Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Metastatic Bone Disease Product
Table 66. Amgen Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Merck & Co Company Details
Table 69. Merck & Co Business Overview
Table 70. Merck & Co Metastatic Bone Disease Product
Table 71. Merck & Co Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 72. Merck & Co Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Metastatic Bone Disease Product
Table 76. Roche Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Metastatic Bone Disease Product
Table 81. Novartis Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Eli Lilly and Company Company Details
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Metastatic Bone Disease Product
Table 86. Eli Lilly and Company Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. Bayer Company Details
Table 89. Bayer Business Overview
Table 90. Bayer Metastatic Bone Disease Product
Table 91. Bayer Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 92. Bayer Recent Development
Table 93. Fresenius Kabi Company Details
Table 94. Fresenius Kabi Business Overview
Table 95. Fresenius Kabi Metastatic Bone Disease Product
Table 96. Fresenius Kabi Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 97. Fresenius Kabi Recent Development
Table 98. BTG plc Company Details
Table 99. BTG plc Business Overview
Table 100. BTG plc Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 101. BTG plc Recent Development
Table 102. Boston Scientific Company Details
Table 103. Boston Scientific Business Overview
Table 104. Boston Scientific Metastatic Bone Disease Product
Table 105. Boston Scientific Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 106. Boston Scientific Recent Development
Table 107. Medtronic Company Details
Table 108. Medtronic Business Overview
Table 109. Medtronic Metastatic Bone Disease Product
Table 110. Medtronic Revenue in Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 111. Medtronic Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Bone Disease Market Share by Type: 2020 VS 2027
Figure 2. Medication Features
Figure 3. Radiation Therapy Features
Figure 4. Surgical Intervention Features
Figure 5. Tumor Ablation Therapy Features
Figure 6. Global Metastatic Bone Disease Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Metastatic Bone Disease Report Years Considered
Figure 11. Global Metastatic Bone Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Metastatic Bone Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Metastatic Bone Disease Market Share by Regions: 2020 VS 2027
Figure 14. Global Metastatic Bone Disease Market Share by Regions (2022-2027)
Figure 15. Global Metastatic Bone Disease Market Share by Players in 2020
Figure 16. Global Top Metastatic Bone Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Bone Disease as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Metastatic Bone Disease Revenue in 2020
Figure 18. Global Metastatic Bone Disease Revenue Market Share by Type (2016-2021)
Figure 19. Global Metastatic Bone Disease Revenue Market Share by Type (2022-2027)
Figure 20. North America Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 22. North America Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 23. North America Metastatic Bone Disease Market Share by Country (2016-2027)
Figure 24. United States Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 28. Europe Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 29. Europe Metastatic Bone Disease Market Share by Country (2016-2027)
Figure 30. Germany Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Metastatic Bone Disease Market Share by Region (2016-2027)
Figure 40. China Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 48. Latin America Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 49. Latin America Metastatic Bone Disease Market Share by Country (2016-2027)
Figure 50. Mexico Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Metastatic Bone Disease Market Share by Country (2016-2027)
Figure 56. Turkey Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Amgen Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 60. Merck & Co Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 65. Fresenius Kabi Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 66. BTG plc Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 67. Boston Scientific Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 68. Medtronic Revenue Growth Rate in Metastatic Bone Disease Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の転移性骨疾患薬物治療市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Medication Treatment …- 転移性骨腫瘍治療のグローバル市場調査 2019年 The global Metastatic Bone Tumor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Metastatic Bone Tumor Treatment volume and value at global level, regional level and company level. From a …
- 世界の転移性骨がん市場規模・現状・予測（2021年-2027年） Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer Market Analysis and Insights: Global Met…
- 世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年） Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer Market Analysis and Insights: Global Met…
- 世界の転移性悪性黒色腫治療市場規模・現状・予測（2021年-2027年） Heart metastatic malignant melanoma is the late stage of tumor development.Treatment is mainly to alleviate symptoms and support the treatment of the whole body, such as anemia, edema, hypoproteinemia.For pleural or pericardial effusion should be punctured as soon as possible or catheter drainage, …